MedPath

PharmacoPhotonics, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Pilot Study to Evaluate Safety, Tolerability, and Performance of the FAST PV Technologyâ„¢ in Chronic Dialysis Patients

Not Applicable
Completed
Conditions
End Stage Renal Disease
Interventions
Device: VFI using the FAST PV Technology
First Posted Date
2021-02-02
Last Posted Date
2023-02-08
Lead Sponsor
FAST BioMedical
Target Recruit Count
10
Registration Number
NCT04733664
Locations
🇺🇸

Richard L. Roudebush VA Medical Center, Indianapolis, Indiana, United States

The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of FAST PV and mGFR Technologyâ„¢

Completed
Conditions
Renal Insufficiency, Chronic
Urologic Diseases
Kidney Diseases
Acute Kidney Injury
Renal Insufficiency
Interventions
Device: VFI
Device: Iohexol
First Posted Date
2017-03-29
Last Posted Date
2018-12-26
Lead Sponsor
FAST BioMedical
Target Recruit Count
32
Registration Number
NCT03095391
Locations
🇺🇸

University of Alabama Birmingham, Division of Nephrology, Birmingham, Alabama, United States

🇺🇸

ICON Early Phase Services, LLC, San Antonio, Texas, United States

FAST GFR: Pilot Study to Evaluate the Safety of the FAST GFR Test in Patients.

Not Applicable
Completed
Conditions
Chronic Kidney Disease
Acute Kidney Injury
Interventions
Device: 75 mg / 6 mL VFIâ„¢
First Posted Date
2013-11-07
Last Posted Date
2017-12-12
Lead Sponsor
FAST BioMedical
Target Recruit Count
33
Registration Number
NCT01978314
Locations
🇺🇸

University of Alabama Birmingham, Division of Nephrology, Birmingham, Alabama, United States

© Copyright 2025. All Rights Reserved by MedPath